Disruptive technology award faculty

2025 DTAC committee

Michaela Miller, MBA (Chair)
Vice President, Technology & Analytics
IQVIA
Boston, Massachusetts

Susan Evans, PhD, FADLM
Principal
BioDecisions Consulting
Los Gatos, California

Lance Ladic, PhD
Director, Innovation Community ManagemenSiemens Healthineers
Princeton, New Jersey

Khushbu Patel, PhD, DABCC, FADLM
Director, Clinical Chemistry and Point-of-Care, Children’s Hospital of Philadelphia
Assistant Professor of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania

Vincent Ricchiuti, PhD, HCLD(ABB), FADLM
Laboratory Director and Discipline Director in Immunology
LabCorp
Dublin, Ohio

Alicja Santos, PhD
CEO
Polonium Foundation
Los Angeles, California

2025 DTAC Finalist Judges

Valerie Dixon 
Senior Partner
Flagship Pioneering
Cambridge, MA

Lonnie Shoff
Former President/CEO
Roche Diagnostics, Thermo Fisher Scientific, Henry Schein, and Antech Diagnostics
Espoo, Finland

Mirko Strange, PhD
Founder & CEO
DxPx Investor & Industry Conference
Düsseldorf, Germany

Reviewers

Christopher Farnsworth, PhD
Washington University in St. Louis
St. Louis, Missouri

Laura Filkins, PhD, D(ABMM)
University of Texas Southwestern Medical Center
Dallas, Texas

Dianne Keen-Kim, PhD, FACMG, HCLD(ABB)
Natera, Inc.
San Carlos, California | Austin, Texas

David J. Ledden, PhD
Siemens Healthineers
Elkhart, Indiana

Giles Sanders, PhD
TTP plc
Cambridgeshire, United Kingdom

Manfred Scholz, PhD
Scholz Consulting Partners LLC
Medford, Massachusetts